Benzinga: World’s First Phase 3 Clinical Trial On MDMA Shows ‘Powerful New Pathway To Healing’

Summary: “Through MAPS’ tireless work, MDMA — a psychedelic empathogen discovered in 1912 and made illegal in 1985 — is inches away from obtaining FDA approval to be used in the treatment of PTSD.”

Benzinga reports on the results of MAPS’ Phase 3 trial of MDMA-assisted therapy for PTSD, calling the study’s success “a milestone for the entire psychedelics industry.” Learn more about the implications of the successful trial.

Originally appearing here.